Developments in neoadjuvant immunotherapy options for earlystage lung cancer patients

Developments in neoadjuvant immunotherapy options for early-stage lung cancer patients

13:23 EDT 11 Jun 2019 | ecancermedicalscience

Dr Luis Raez speaks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about exciting developments in lung cancer treatments from this year's meeting. Dr Raez also provides his insight into the exciting developments in...

More From BioPortfolio on "Developments in neoadjuvant immunotherapy options for early-stage lung cancer patients"